ATE221784T1 - Arzneimittel zur heilung von thrombozytopenie - Google Patents

Arzneimittel zur heilung von thrombozytopenie

Info

Publication number
ATE221784T1
ATE221784T1 AT96907755T AT96907755T ATE221784T1 AT E221784 T1 ATE221784 T1 AT E221784T1 AT 96907755 T AT96907755 T AT 96907755T AT 96907755 T AT96907755 T AT 96907755T AT E221784 T1 ATE221784 T1 AT E221784T1
Authority
AT
Austria
Prior art keywords
thrombocytopenia
cure
medicine
thrombocyte
thrombocytes
Prior art date
Application number
AT96907755T
Other languages
English (en)
Inventor
Yasushi Shimonaka
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE221784T1 publication Critical patent/ATE221784T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5443—IL-15
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96907755T 1995-04-02 1996-04-02 Arzneimittel zur heilung von thrombozytopenie ATE221784T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11221895 1995-04-02
PCT/JP1996/000898 WO1996031230A1 (en) 1995-04-02 1996-04-02 Medicinal composition for curing thrombocytopenia

Publications (1)

Publication Number Publication Date
ATE221784T1 true ATE221784T1 (de) 2002-08-15

Family

ID=14581220

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96907755T ATE221784T1 (de) 1995-04-02 1996-04-02 Arzneimittel zur heilung von thrombozytopenie

Country Status (7)

Country Link
US (1) US6258352B1 (de)
EP (1) EP0823257B1 (de)
AT (1) ATE221784T1 (de)
AU (1) AU700250B2 (de)
CA (1) CA2217122C (de)
DE (1) DE69622854T2 (de)
WO (1) WO1996031230A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0823257B1 (de) 1995-04-02 2002-08-07 Chugai Seiyaku Kabushiki Kaisha Arzneimittel zur Heilung von Thrombozytopenie
WO1999018997A1 (en) * 1997-10-14 1999-04-22 Chugai Seiyaku Kabushiki Kaisha Potentiator for antibody against lymphoid tumor
KR20020025990A (ko) * 1999-08-23 2002-04-04 나가야마 오사무 에이치엠1.24 항원의 발현 증강제
JP3986439B2 (ja) * 2001-02-07 2007-10-03 中外製薬株式会社 造血器腫瘍の治療剤
KR100911951B1 (ko) * 2001-08-23 2009-08-13 젠맵 에이/에스 인터루킨 15 (ｉｌ-15)에 대하여 특이적인 인간 항체
US7247304B2 (en) * 2001-08-23 2007-07-24 Genmab A/S Methods of treating using anti-IL-15 antibodies
US7329405B2 (en) * 2001-08-23 2008-02-12 Genmab A/S Human antibodies specific for interleukin 15 (IL-15)
WO2005023289A1 (ja) * 2003-09-08 2005-03-17 Intellectual Property Consulting Incorporated 慢性ｃ型肝炎を治療するための医薬組成物
WO2015054701A2 (en) * 2013-10-13 2015-04-16 Nova Southeastern University Analyzing immune signaling networks for identification of therapeutic targets in complex chronic medical disorders, identification of a natural killer cell population as a potential therapeutic target for gulf war illness & myalgic encephalomyelitis/chronic fatigue syndrome, and modulation of natural killer cell function by stimulation with interleukin 15
CN104212808B (zh) * 2014-09-05 2017-03-08 中国科学院广州生物医药与健康研究院 重组人白介素15长肽段及其生产方法
US12605349B2 (en) 2024-09-05 2026-04-21 Orbus Therapeutics, Inc. Methods of treating grade 3 astrocytoma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747024A (en) * 1993-03-08 1998-05-05 Immunex Corporation Vaccine adjuvant comprising interleukin-15
US5552303A (en) * 1993-03-08 1996-09-03 Immunex Corporation DNA encoding epithelium-derived T-cell factor
WO1995027722A1 (en) * 1994-04-06 1995-10-19 Immunex Corporation Interleukin-15
EP0823257B1 (de) 1995-04-02 2002-08-07 Chugai Seiyaku Kabushiki Kaisha Arzneimittel zur Heilung von Thrombozytopenie

Also Published As

Publication number Publication date
CA2217122A1 (en) 1996-10-10
EP0823257A1 (de) 1998-02-11
AU700250B2 (en) 1998-12-24
CA2217122C (en) 2004-10-26
DE69622854D1 (de) 2002-09-12
EP0823257B1 (de) 2002-08-07
AU5123696A (en) 1996-10-23
WO1996031230A1 (en) 1996-10-10
US6258352B1 (en) 2001-07-10
DE69622854T2 (de) 2003-04-10
EP0823257A4 (de) 1998-04-01

Similar Documents

Publication Publication Date Title
FR2698875B1 (fr) Système silicone modulateur d'adhérence et son utilisation pour la préparation de compositions antiadhérentes durcissables.
DE69622854D1 (de) Arzneimittel zur Heilung von Thrombozytopenie
AU7362496A (en) Dimer-selective rxr modulators and methods for their use
ATE207080T1 (de) Multivalente antigen-bindende proteine
ATE274056T1 (de) Kombination pdgf, kgf, igf und igfbp zur wundheilung
ATE161737T1 (de) Biokeramisches system zur abgabe von bioaktiven stoffen
DK0871631T3 (da) Antiparasitære marcfortiner og paraherquamider
DE69521521D1 (de) Mono- oder polyfunktionelle konjugate von polylysine
EP0626402A3 (de) Verfahren zur Herstellung von linearen monofunktionellen und zweifunktionalen telechelen Polymerisaten und davon hergestellte Zusammensetzungen.
DK0625354T3 (da) Lægemiddel indeholdende underenhed p40 af interleukin-12
DE69808620D1 (de) Universell verwendbares bluttplasma
DE69325393D1 (de) Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen
DK0956351T3 (da) Tumornekrosefaktorbeslægtet ligand
ES8106720A1 (es) Un procedimiento para la preparacion de diariltiofenos.
DK0587087T3 (da) Substituerede cyclohexan-derivater til behandling af sygdomme
DE69942454D1 (de) Hohlraum-induzierte allosterische modifikation von intermolekularen interaktionen und verfahren zur identifikation von verbindungen, die diese bewirken.
DK0386700T3 (da) Anvendelse af inhalerede "loop"-diuretika til behandling af allergenfremkaldte, nasale reaktioner
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
FI945000A0 (fi) Menetelmä (S)-amino-1-substituoitujen pyrrolidiinien valmistamiseksi
FR2695804B1 (fr) Compositions nutritives ou médicamenteuses pour l'administration aux ruminants à base de chitosane.
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
DE69626522D1 (de) Peptide mit pronociceptiveigenschaften
ES2142840T3 (es) Proteina que se une al interferon alfa/beta, su preparacion y las composiciones farmaceuticas que la contienen.
DE69626050D1 (de) Pharmazeutische zusammensetzung enthaltend interferon-gamma stimulatoren
DK0655251T3 (da) Farmaceutisk præparat til forebyggelse eller behandling af knoglebrud

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties